Prognostic value of tissue and circulating levels of IMP3 in prostate cancer

High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer

(2012) Tibor Szarvas et al.   BJU INTERNATIONAL

Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?

(2012) Jessica L. Bell et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy

(2011) Thomas F. Chromecki et al.   BJU INTERNATIONAL

Erratum: Cancer Statistics, 2010

(2011)   CA-A CANCER JOURNAL FOR CLINICIANS

Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2

(2011) Ramaswamy Suvasini et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Risk stratification of oral cancer patients using a combined prognostic factor including lymph node density and biomarker

(2011) Ki-Yeol Kim et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores

(2010) Kristian Ikenberg et al.   BMC CANCER

IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology

(2010) Katsuhide Ikeda et al.   HUMAN PATHOLOGY

Diffuse Expression of RNA-Binding Protein IMP3 Predicts High-Stage Lymph Node Metastasis and Poor Prognosis in Colorectal Adenocarcinoma

(2009) Ray-Hwang Yuan et al.   ANNALS OF SURGICAL ONCOLOGY

Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer

(2009) Koji Kono et al.   CANCER SCIENCE

IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype

(2009) Otto Walter et al.   HUMAN PATHOLOGY

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the Bladder

(2008) L. Sitnikova et al.   CLINICAL CANCER RESEARCH